In the News

04/23/2019 12:00 AM  | Inside Sources
04/22/2019 12:00 AM  | The Washington Times
02/26/2019 12:00 AM  | The Washington Times
02/19/2019 12:00 AM  | Cancer Therapy Advisor
01/08/2019 12:00 AM  | The Washington Times
01/06/2019 12:00 AM  | RealClearHealth
12/17/2018 12:00 AM  | Morning Consult
12/04/2018 12:00 AM  | The Washington Times
11/11/2018 12:00 AM  | Echo Press
Sign Up for Our Email Newsletter

RECENT NEWS

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta...  Read more

FDA  Authorizes Pfizer Covid-19 Vaccine Booster for Ages 12-15
  • NEWSY
  • 01/04/2022 12:00 AM

FDA Authorizes Pfizer Covid-19 Vaccine Booster for Ages 12-15

CMPI's Peter Pitts discusses FDA approval of Pfizer COVID vaccine booster for children ages 12-15...  Read more

Should We Rethink The FDA Commissionership?

Should We Rethink The FDA Commissionership?

When one considers the FDA’s mission—to independently protect consumers and advance the public health—it is not at all cl...  Read more

DRUGWONKS BLOG